Skip to main content
Clinical Trials/NCT03969394
NCT03969394UnknownNot Applicable

The Prognostic Role of the Right Ventricle in Patients With Heart Failure or Congenital Heart Disease

Cliniques universitaires Saint-Luc- Université Catholique de Louvain2 sites in 1 country100 target enrollmentStarted: June 1, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
100
Locations
2
Primary Endpoint
overall survival

Study Overview

Brief Summary

The objectives are

  1. to validate quantification of 2D and 3D right ventricular strian measurements of right ventricular performance in cross comparison to cardiac MRI and to evaluate its relation to right ventricular fibrosis.
  2. to evaluate their prognostic value in patients with heart failure with either depressed or preserved ejection fraction.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult Patients with heart failure

Exclusion Criteria

  • Renal failure
  • Contraindications to Cardiac MRI

Arms & Interventions

Heart Failure Patients

Experimental

Patients with Heart Failure

Intervention: Medical imaging (Diagnostic Test)

Outcomes

Primary Outcomes

overall survival

Time Frame: 3 years

Secondary Outcomes

  • Heart Failure(3 years)

Investigators

Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials